Slingshot members are tracking this event:
Phase 1/2 initial data of Genmab's (GMAB) Enapotamab vedotin in Solid tumors to be presented at IASLC 2019 WCLC September 8, 2019
Slingshot Insights Explained
Sep 08, 2019
Don’t see a project related to the catalyst you care about?
Related Keywords Enapotamab Vedotin, Solid Tumors, Iaslc